Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study
- PMID: 19451353
- PMCID: PMC2752297
- DOI: 10.1161/CIRCULATIONAHA.108.816900
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study
Abstract
Background: Cardiovascular factors are associated with cognitive decline. Antioxidants may be beneficial.
Methods and results: The Women's Antioxidant Cardiovascular Study was a trial of vitamin E (402 mg every other day), beta carotene (50 mg every other day), and vitamin C (500 mg daily) for the secondary prevention of cardiovascular disease. From 1995 to 1996, women > or =40 years of age with cardiovascular disease or > or =3 coronary risk factors were randomized. From 1998 to 1999, a cognitive function substudy was initiated among 2824 participants > or =65 years of age. With 5 cognitive tests, cognition was assessed by telephone 4 times over 5.4 years. The primary outcome was a global composite score averaging all scores; repeated-measures analyses were used to examine cognitive change over time. Vitamin E supplementation and beta carotene supplementation were not associated with slower rates of cognitive change (mean difference in change for vitamin E versus placebo, -0.01; 95% confidence interval, -0.05 to 0.04; P=0.78; for beta carotene, 0.03; 95% confidence interval, -0.02 to 0.07; P=0.28). Although vitamin C supplementation was associated with better performance at the last assessment (mean difference, 0.13; 95% confidence interval, 0.06 to 0.20; P=0.0005), it was not associated with cognitive change over time (mean difference in change, 0.02; 95% confidence interval, -0.03 to 0.07; P=0.39). Vitamin C was more protective against cognitive change among those with new cardiovascular events during the trial (P for interaction=0.009).
Conclusions: Antioxidant supplementation did not slow cognitive change among women with preexisting cardiovascular disease or cardiovascular disease risk factors. A possible late effect of vitamin C or beta carotene among those with low dietary intake on cognition warrants further study.
Figures
Similar articles
-
Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial.Am J Clin Nutr. 2009 Aug;90(2):429-37. doi: 10.3945/ajcn.2009.27491. Epub 2009 Jun 2. Am J Clin Nutr. 2009. PMID: 19491386 Free PMC article. Clinical Trial.
-
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.Arch Intern Med. 2007 Aug 13-27;167(15):1610-8. doi: 10.1001/archinte.167.15.1610. Arch Intern Med. 2007. PMID: 17698683 Free PMC article. Clinical Trial.
-
Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.J Natl Cancer Inst. 2009 Jan 7;101(1):14-23. doi: 10.1093/jnci/djn438. Epub 2008 Dec 30. J Natl Cancer Inst. 2009. PMID: 19116389 Free PMC article. Clinical Trial.
-
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.Ann Epidemiol. 2000 Feb;10(2):125-34. doi: 10.1016/s1047-2797(99)00042-3. Ann Epidemiol. 2000. PMID: 10691066 Review.
-
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD011906. doi: 10.1002/14651858.CD011906.pub2. Cochrane Database Syst Rev. 2018. PMID: 30556597 Free PMC article.
Cited by
-
Relationship between Serum and Brain Carotenoids, α-Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study.J Aging Res. 2013;2013:951786. doi: 10.1155/2013/951786. Epub 2013 Jun 9. J Aging Res. 2013. PMID: 23840953 Free PMC article.
-
Identifying Dietary Patterns Associated with Mild Cognitive Impairment in Older Korean Adults Using Reduced Rank Regression.Int J Environ Res Public Health. 2018 Jan 9;15(1):100. doi: 10.3390/ijerph15010100. Int J Environ Res Public Health. 2018. PMID: 29315276 Free PMC article.
-
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.Br J Clin Pharmacol. 2013 Mar;75(3):738-55. doi: 10.1111/bcp.12058. Br J Clin Pharmacol. 2013. PMID: 23384081 Free PMC article. Review.
-
Reactive Oxygen Species (ROS) in Metabolic Disease-Don't Shoot the Metabolic Messenger.Int J Mol Sci. 2025 Mar 14;26(6):2622. doi: 10.3390/ijms26062622. Int J Mol Sci. 2025. PMID: 40141264 Free PMC article. Review.
-
Vitamin C Status and Cognitive Function: A Systematic Review.Nutrients. 2017 Aug 30;9(9):960. doi: 10.3390/nu9090960. Nutrients. 2017. PMID: 28867798 Free PMC article.
References
-
- Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev. 2002 Feb;1(1):61–77. - PubMed
-
- Pratico D, Clark CM, Liun F, et al. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol. 2002;59:972–976. - PubMed
-
- Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001 Aug;60(8):759–767. - PubMed
-
- Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005 Jun 9;352(23):2379–2388. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical